Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% Diquafosol for Vernal Keratoconjunctivitis
NCT06903884Phase 3Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Feb 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diquafosol in Vernal Keratoconjunctivitis (VKC), sponsored by The University of Hong Kong. Started Feb 2026; status: recruiting.
02
Drugs
diquafosol
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT06903884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06903884.